Rep. Brian Babin

Iran Nuclear Verification Act This bill prohibits the United States from becoming a party to the Joint Comprehensive Plan of Action (JCPOA) or any other agreement with Iran that relates to Iran's nuclear program until the President makes certain certifications. The JCPOA is an agreement, signed by Iran and several other world powers (including the United States), that places restrictions on Iran's nuclear program in exchange for certain sanctions relief. The United States withdrew from the JCPOA in 2018. The United States may not become a party to any such agreement until the President certifies to Congress that United Nations nuclear inspectors are allowed full access to all of Iran's nuclear facilities, and that they have completed their comprehensive report relating to those facilities.

Prostate-Specific Antigen Screening for High-risk Insured Men Act or the PSA Screening for HIM Act This bill requires private health insurance plans to cover preventive prostate cancer screenings that are not already covered under the recommendations of the U.S. Preventive Services Task Force for men with a family history of prostate cancer, without imposing any cost-sharing requirement.

This resolution honors the life and legacy of Rush Limbaugh and commends him for his devotion to the United States.

Opposing Business with Chinese Military Companies Act This bill requires the President to exercise certain economic powers, such as investigating or prohibiting payments, with respect to an entity that is engaging in economic activities in the United States and is (1) affiliated with China's government or military, or (2) owned or controlled by an entity affiliated with China's defense industrial base. (The President currently has such powers but is not required to exercise them.) The bill extends to December 31, 2026, a provision requiring the Department to Defense to annually report to Congress an updated list of such entities.

This joint resolution nullifies the action of the District of Columbia Council in approving the Minor Consent for Vaccinations Amendment Act of 2020, enacted by the council on December 23, 2020, and transmitted on February 1, 2021, to Congress pursuant to the District of Columbia Home Rule Act. The act authorizes a minor, 11 years of age or older, to consent to receive a vaccine if the minor is capable of meeting the informed consent standard and the vaccine is recommended by the United States Advisory Committee on Immunization Practices and will be provided in accordance with its recommended immunization schedule.

This resolution expresses support for the formal resubmission of the United States' withdrawal from the Paris Agreement.

This resolution acknowledges the importance of the U.S.-Egypt partnership and Egypt's role in the fight against terrorism and violent extremism. It also urges the Egyptian government to (1) enact serious and legitimate reforms to ensure that Coptic Christians have the same rights and opportunities as other Egyptian citizens, (2) complete the process of church certification, and (3) take steps to end the culture of impunity for attacks on Christians.

No Taxpayer Funding for the Chinese Communist Party Act of 2021 This bill requires the Department of Justice to report to Congress on the extent to which China has benefited from U.S. taxpayer-funded research. The report shall also contain information including (1) a list of U.S. government-funded entities that have hired Chinese nationals; and (2) a list of U.S. government programs in the science, technology, engineering, and math fields that have cooperated or affiliated with research institutions in China or Chinese Communist Party entities.

No taxpayer funding for United Nations Human Rights Council Act This bill prohibits the Department of State from making contributions to the United Nations Human Rights Council, either as a percentage of the U.S. contribution to the regular budget of the United Nations or as a voluntary contribution to the council.

Chinese Research Funds Accounting Act This bill directs the Government Accountability Office (GAO) to conduct a study on federal funding made available to entities located in China or majority owned or controlled by the Chinese Communist Party for research in the five years prior to enactment of this bill. Not later than 120 days after the enactment of this bill, the GAO shall brief Congress on the data that is available with respect to federal funding made available to such entities for research.